HER2 targeted molecular MR imaging using a de novo designed protein contrast agent - sprookjes - yvandenbroek - TriplyDB

HER2 targeted molecular MR imaging using a de novo designed protein contrast agent

HER2 targeted molecular MR imaging using a de novo designed protein contrast agent

http://www.wikidata.org/entity/Q28477503

about

PEGylation of protein-based MRI contrast agents improves relaxivities and biocompatibilities Tailoring encodable lanthanide-binding tags as MRI contrast agents Design of ProCAs (protein-based Gd(3+) MRI contrast agents) with high dose efficiency and capability for molecular imaging of cancer biomarkers Design of a novel class of protein-based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkers Molecular imaging of EGFR/HER2 cancer biomarkers by protein MRI contrast agents Antibody-based imaging of HER-2: moving into the clinic.Positive contrast high-resolution 3D-cine imaging of the cardiovascular system in small animals using a UTE sequence and iron nanoparticles at 4.7, 7 and 9.4 T.In vivo screening of hepatocellular carcinoma using AC susceptibility of anti-alpha fetoprotein-activated magnetic nanoparticles.Ultrashort echo time (UTE) imaging of receptor targeted magnetic iron oxide nanoparticles in mouse tumor models C5b-9-targeted molecular MR imaging in rats with Heymann nephritis: a new approach in the evaluation of nephrotic syndrome.Improving the magnetic resonance imaging contrast and detection methods with engineered magnetic nanoparticles Tracking T-cells in vivo with a new nano-sized MRI contrast agent Characteristics of magnetic labeling on liver tumors with anti-alpha-fetoprotein-mediated Fe3O4 magnetic nanoparticles.GRPR-targeted Protein Contrast Agents for Molecular Imaging of Receptor Expression in Cancers by MRI Strategies for Target-Specific Contrast Agents for Magnetic Resonance Imaging Anti-αvβ3 antibody guided three-step pretargeting approach using magnetoliposomes for molecular magnetic resonance imaging of breast cancer angiogenesis.Gadolinium-based contrast agents for magnetic resonance cancer imaging.Anti-CEA-functionalized superparamagnetic iron oxide nanoparticles for examining colorectal tumors in vivo Molecular characterization of breast cancer cell lines through multiple omic approaches.Visible to Near-Infrared Fluorescence Enhanced Cellular Imaging on Plasmonic Gold Chips.A cell-penetrating protein designed for bimodal fluorescence and magnetic resonance imaging.Prostate-specific membrane antigen targeted protein contrast agents for molecular imaging of prostate cancer by MRI.Targeted tumor MRI with gadobutrol-loaded anti-HER2 immunoliposomes.Tracking embryonic hematopoietic stem cells to the bone marrow: nanoparticle options to evaluate transplantation efficiency

P2860

Q24594884-24AD8460-1410-401C-9CCA-C609E690F33E Q27683418-1D1F1428-D810-4B45-A157-44905DDD3DFE Q28235682-1E38A76D-D301-4A91-BD36-5D2CE0399C65 Q28283802-12864A67-5D80-4AA0-A665-09DE18BB32D9 Q28304646-2D7A4976-50A4-424C-B506-DC98F66978BD Q30423880-41DEF377-5E70-4769-8AE5-5F4C094D05A5 Q30656936-55EF11B6-9BED-4A5A-AD4A-B332B3D78B1C Q34442056-042A9373-E44A-4936-92EA-B1B03E00DBF6 Q34662745-9A6D1519-8710-427F-9023-B3AEF1F3E0AD Q35181694-44BC1B50-C8DD-4375-A980-2A7DE630FB3A Q35687164-2B8A38B3-9D21-4E93-B3EE-6B5D9F5F45FC Q36060729-CDC67295-90F3-421E-9F3B-F6C8467CF60C Q36083221-EEB19536-EC18-40F2-A804-6E8FFA0D7528 Q36291569-6BBB4B4E-6C4D-4F67-B6DE-334D50BE23EC Q36517070-B64E0BBD-8ECE-4BA4-9685-7154F1B0F3B4 Q36543499-99BD3672-4005-4A89-8EFC-268979CE0D0C Q36555415-CF643562-5790-47F7-9175-DBD57B0190A5 Q37366302-5BCD662B-2C6A-436E-888A-2206C6B7EFBA Q38701221-F2110C61-6141-4664-AAC7-F87C14D95961 Q38811907-AF58A7F0-7425-42F5-AE95-9CEC2BB1E888 Q40989828-00A113E1-1FBB-461A-9A91-7E943A309E21 Q41131993-1C68719B-448F-481D-8C57-DA18819B50D1 Q51548324-7B73938B-BEBB-4100-98B5-09BC2A99BEB4 Q57181738-1AE26CC1-2215-45A8-B2D0-AE3D32259748

P2860

HER2 targeted molecular MR imaging using a de novo designed protein contrast agent

http://www.wikidata.org/entity/Q28477503

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

HER2 targeted molecular MR imaging using a de novo designed protein contrast agent

@ast

HER2 targeted molecular MR imaging using a de novo designed protein contrast agent

@en

HER2 targeted molecular MR imaging using a de novo designed protein contrast agent

@nl

type

label

HER2 targeted molecular MR imaging using a de novo designed protein contrast agent

@ast

HER2 targeted molecular MR imaging using a de novo designed protein contrast agent

@en

HER2 targeted molecular MR imaging using a de novo designed protein contrast agent

@nl

prefLabel

HER2 targeted molecular MR imaging using a de novo designed protein contrast agent

@ast

HER2 targeted molecular MR imaging using a de novo designed protein contrast agent

@en

HER2 targeted molecular MR imaging using a de novo designed protein contrast agent

@nl

P1433

Q28477503-03E5C4A5-2BD9-4EE3-9B2F-BB89DA259CE5

P1476

Q28477503-A5195B9A-66B9-4B9C-80D8-B76FEABE9286

P2093

Q28477503-0949C3DD-123E-461E-8C38-023468AC2399

Q28477503-11A8D2EA-D7B9-4E99-A131-522C02867C7B

Q28477503-3D6EFE1D-40C7-45B9-B7E3-894EB278DED1

Q28477503-5ED64D56-924A-4A89-851F-D88A2FDA70DE

Q28477503-68234BC1-58B0-45E8-AB76-0955DAA88193

Q28477503-7281EE59-C7F4-43E4-9BF0-846471201BEC

Q28477503-88EA68B2-EB2A-4CAC-B1BD-431B603478E8

Q28477503-A8313D47-236D-403A-A80E-B469A35B7D27

Q28477503-E6B12935-C4E0-4F9D-9DAA-C5028DB3C7BC

Q28477503-EE95830F-EA76-4C35-A61E-7E0F01FD37FF

P2860

Q28477503-0F56641D-88EF-44B9-B2AA-62B20F9D9D26

Q28477503-0F93502B-8C28-4ACC-8712-0C431208B81D

Q28477503-0FBEA6E4-319A-4FE3-B83D-18C4BBB24497

Q28477503-158697B6-A81D-4E69-99F7-FB69AECFDE93

Q28477503-19518BAA-07D8-46E3-921F-EFD69AF1190F

Q28477503-26560DC9-A81C-4046-AC5C-2209DF5EA88F

Q28477503-367D6CC0-F6C3-4628-843C-A9E1D097EE49

Q28477503-3DC148AC-F424-4197-8A93-D41113111EA6

Q28477503-48E9AE83-2221-4EA9-8177-AFFFC89C5CFB

Q28477503-5358EE0E-B133-4C4C-84F4-16DC24ACE31D

P304

Q28477503-AD975DFA-4917-4B23-95C8-1027B516FA10

P31

Q28477503-FF668095-D832-49FE-A0BC-119F8A435FD1

P356

Q28477503-C6FEE09D-2F87-4840-ACF9-EFF97F91644E

P407

Q28477503-4F9EF23D-0FA7-4F68-83F8-A30F9369931A

P433

Q28477503-5F3B5600-F025-4579-8CDD-9FF8F1BC11EA

P478

Q28477503-6808B5E8-9BC0-446F-B1E2-EAD2DF96C315

P577

Q28477503-E69776BF-B16B-4815-83CA-8775A06AFD16

P5875

Q28477503-8088BBF4-F669-4BBD-B9B6-0183691306AE

P698

Q28477503-D4D5738D-7DD1-4F77-8287-B57DAB1F0E2B

P921

Q28477503-8C3441CB-AAFF-42B7-8DDA-8355C385BB47

Q28477503-C69C378C-D7DF-47D2-B3CC-173E108EF2EC

P932

Q28477503-DCB8B8CD-2699-48ED-8458-BAEE2DFDC833

P356

JOURNAL.PONE.0018103

P1433

P1476

HER2 targeted molecular MR imaging using a de novo designed protein contrast agent

@en

P2093

Hans E Grossniklaus

http://www.w3.org/2001/XMLSchema#string

Hua Yang

http://www.w3.org/2001/XMLSchema#string

Hui Mao

http://www.w3.org/2001/XMLSchema#string

Jenny J Yang

http://www.w3.org/2001/XMLSchema#string

Jie Jiang

http://www.w3.org/2001/XMLSchema#string

Jingjuan Qiao

http://www.w3.org/2001/XMLSchema#string

Ling Wei

http://www.w3.org/2001/XMLSchema#string

Lixia Wei

http://www.w3.org/2001/XMLSchema#string

Liya Wang

http://www.w3.org/2001/XMLSchema#string

Robert Long

http://www.w3.org/2001/XMLSchema#string

P2860

Chemical exchange saturation transfer contrast agents for magnetic resonance imaging

Imaging in the era of molecular oncology.

Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab

Tissue-specific MR contrast agents.

Towards targeted MRI: new MRI contrast agents for sialic acid detection.

Magnetic resonance imaging visualization of targeted cells by the internalization of supramolecular adducts formed between avidin and biotinylated Gd3+ chelates.

Rational design of protein-based MRI contrast agents

Selection and characterization of HER2/neu-binding affibody ligands.

PAMAM dendrimer-based contrast agents for MR imaging of Her-2/neu receptors by a three-step pretargeting approach

HER2 overexpression in various tumor types, focussing on its relationship to the development of invasive breast cancer.

P304

e18103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0018103

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50940484

http://www.w3.org/2001/XMLSchema#string

P698

21455310

http://www.w3.org/2001/XMLSchema#string

P921

molecular design

P932

3063795

http://www.w3.org/2001/XMLSchema#string